Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model

Journal of Neuroscience Research

Volumn 48, Issue 5, 1997, Pages 449-464

  Knyihár Csillik, Elizabeth ^a   Tajti, János ^a   Samsara, Mohtasham ^a   Sáry, Gyula ^b   Slezák, Sándor ^c   Vécsei, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

CGRP; dura mater; stimulation; sumatriptan; trigeminal (Gasserian) ganglion

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; PROTEIN C FOS; SEROTONIN 1D RECEPTOR; SUMATRIPTAN; SUMATRIPTAN SUCCINATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DURA MATER; FEMALE; GENE EXPRESSION; INTERNEURON; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIGRAINE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; TRIGEMINAL NUCLEUS;

EID: 1842366065     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970601)48:5<449::AID-JNR6>3.3.CO;2-X     Document Type: Article

References (48)

1. Andres KH, During M, Muszynski K, Schmidt RF (1987): Nerve fibers and their terminals of the dura mater encephali of the rat. Anat Embryol (Berl) 175:289-301.
2. Beattie DT, Connor HE, Feniuk W, Humphrey PPA (1994): The pharmacology of sumatriptan. Rev Contemp Pharmacother 5:285-294.
3. Boess FG, Martin IL (1994): Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317.
4. Bullitt E (1990): Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 296:517-530.
5. Buzzi MG, Moskowitz MA (1992): The trigemino-vascular system and migraine. Pathol Biol (Paris) 40:313-317.
6. Buzzi MG, Carter WB, Shimizu T, Heath H, Moskowitz MA (1991): Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30:1193-1200.
7. Connor HE, Feniuk W, Humphrey PPA (1989): Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol 96:379-387.
8. Csillik B (1996): Neuropeptides as signal transmitters in nociception and pain. Nova Acta Leopoldina NF 294:93-101.
9. Dechant KL, Clissold SP (1992): Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 43:776-798.
10. Edvinsson L, Uddman R (1981): Adrenergic, cholinergic and peptidergic nerve fibres in dura mater-involvement in headache? Cephalalgia 1:175-179.
11. Goadsby PJ, Edvinsson L (1993): The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48-56.
12. Goadsby PJ, Edvinsson L (1994): Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attack therapies. Brain 117:427-434.
13. Goadsby PJ, Edvinsson L, Ekman R (1990): Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:1873-1878.
14. Henkes H, May A, Kühne D, Berg-Dammer E, Diener HC (1996): Sumatriptan: vasoactive effect on human dural vessels, demonstrated by subselective angiography. Cephalalgia 16:224-230.
15. Herdegen T, Rudiger S, Mayer B, Bravo R, Zimmermann M (1994): Expression of nitric oxide synthase and colocalization with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Brain Res Mol Brain Res 22:245-258.
16. Huang Z, Byun B, Matsubara T, Moskowitz MA (1993): Timedependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11. Br J Pharmacol 108:331-335.
17. Humphrey PP, Feniuk W, Marriott AS, Tanner RJ, Jackson MR, Tucker ML (1991): Preclinical studies on the anti-migraine drug, sumatriptan. Eur Neurol 31:282-290.
18. Hunt SP, Pini A, Evan G (1987): Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328:632-634.
19. Jansen J, Edvinsson L, Mortensen A, Olesen J (1992): Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia 12:202-205.
20. Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ (1993): Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629:95-102.
21. Keller JT, Marfurt CF (1991): Peptidergic and serotonergic innervation of the rat dura mater. J Comp Neurol 309:515-534.
22. Knyihár-Csillik E, Tajti J, Samsam M, Sáry G, Vécsei L (1995): Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: a possible model of migraine headache. Neurosci Lett 184:189-192.
23. Knyihár-Csillik E, Samsam M, Sáry G, Tajti J, Buzás P, Vécsei L (1996): Anatomical basis of headache: changes in the intracellular equilibrium of a pain-related neuropeptide in an experimental migraine model. Annals of Anatomy 178 Suppl: 220.
24. Kovács K, Kapócs G, Widerlöv E, Ekman R, Vécsei L, Jelencsik I, Csanda E (1991): Suboccipital cerebrospinal fluid and plasma concentrations of corticotrotpin-releasing hormone and calcitonin gene-related peptide in patients with common migraine. Nord Psykiatr Tridsskr 45:11-16.
25. Lee JH, Wilcox GL, Beitz AJ (1992): Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. Neuroreport 3:841-844.
26. Lee JH, Price RH, Williams FG, Mayer B, Beitz AJ (1993): Nitric oxide synthase is found in some spinothalamic neurons and in neuronal processes that appose spinal neurons that express Fos induced by noxious stimulation. Brain Res 608:324-333.
27. Menetrey D, Gannon A, Levine JD, Basbaum AI (1989): Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol 285:177-195.
28. Molander C, Hongpaisan J, Grant G (1992): Changing pattern of c-fos expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat. Neuroscience 50:223-236.
29. Morgan JI, Curran T (1986): Role of ion flux in the control of c-fos expression. Nature 322:552-555.
30. Morgan PF, Nakajima T, Linnoila M (1988): Psychological induction of brain c-fos mRNA. Abstr Soc Neurosci 1:289.
31. Moskowitz MA (1984): The neurobiology of vascular head pain. Ann Neurol 16:157-168.
32. Moskowitz MA (1992): Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13:307-311.
33. Mugniani E, Berrebi AS, Morgan JI, Curran T (1989): Fos-like immunoreactivity induced by seizure in mice is specifically associated with euchromatin in neurons. Eur J Neurosci 1:46-52.
34. Nozaki K, Moskowitz MA, Boccalini P (1992): CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 106:409-415.
35. O'Connor TP, van der Kooy D (1988): Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 8:2468-2476.
36. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen NA, Andersen AR (1990): Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28:791-798.
37. Peroutka SJ (1993): Serotonin (5-hydroxytryptamine) receptor subtypes: clinical relevance. In Smith B, Adelman G (eds): "Neuroscience Year. Suppl. 3 to the Encyclopedia of Neuroscience." Berlin: Birkhauser, pp 145-147.
38. Persson JK, Hongpaiusan J, Molander C (1993): C-fos expression in gracilothalamic tract neurons after electrical stimulation of the injured sciatic nerve in the adult rat. Somatosens Mot Res 10:475-483.
39. Russell MB, Holm-Thomson OE, Nielsen MR, Cleal A, Pilgrim AJ, Olesen J (1994): A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Cephalalgia 14:291-296.
40. Saxena PR (1994): The pathogenesis and pharmacology of migraine. Rev Contemp Pharmacother 5:259-269.
41. Schneider JS, Denaro JJ, Olezabal UE, Leard HO (1981): Stereotaxic atlas of the trigeminal ganglion in rat, cat and monkey. Brain Res Bull 7:93-95.
42. Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ (1995): Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 34:255-261.
43. Sternberger LA, Hardy PH, Cusulis JJ (1970): The unlabeled antibody enzyme method of immunocytochemistry. J Histochem Cytochem 18:315-335.
44. Strassman AM, Mineta Y, Vos BP (1994): Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci 14:3725-3735.
45. Welch KMA (1993): Drug therapy of migraine. N Engl J Med 329:1476-1483.
46. Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC, Steiner TJ (1995): Migraine and cluster headache-their management with sumatriptan: a critical review of current clinical experience. Cephalalgia 15:337-357.
47. Zagami AS, Goadsby PJ, Edvinsson L (1990): Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16:69-75.
48. Zamboni L, DeMartino C (1967): Buffered picric acid-formaldehyde: a new rapid fixation for electron microscopy. J Cell Biol 35:18A.